Strides Pharma Science Limited — Important, 23-01-2025: General Updates

OneSource Specialty Pharma Limited has received final listing and trading approval for its equity shares from both the BSE and NSE. Trading is set to commence on January 24, 2025, with OneSource's scrip code listed as ONESOURCE on NSE and 544292 on BSE. This marks a significant step for OneSource as it positions itself within the market as India's first specialty pharma Contract Development and Manufacturing Organization (CDMO). The initiation of trading is anticipated to enhance visibility and attract potential investors, underscoring positive growth potential for the company within the pharmaceutical sector. Watch closely for market reactions and performance indicators following the trading commencement.